Literature DB >> 3454316

Pattern electroretinogram and visual evoked cortical potential in ethambutol optic neuropathy.

Y Kakisu1, E Adachi-Usami, A Mizota.   

Abstract

Forty-one eyes in 21 cases of ethambutol optic neuropathy were investigated for the pattern visual evoked cortical potential (VECP) and the pattern electroretinogram (ERG). In 21 of the eyes the disappearance VECP responses were not detectable. In the other 20 eyes the peak latency and amplitude of the disappearance VECP were delayed and decreased significantly compared with normal eyes. The recovery of the peak latency of the disappearance VECP in ethambutol optic neuropathy was faster than that of the amplitude. Twelve eyes in six patients were studied by pattern reversal ERG. Though the mean peak latency of the pattern ERG was within normal limits, the mean amplitude was decreased significantly. Our investigations indicated that ethambutol optic neuropathy disturbed not only the optic nerve but also the retina.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3454316     DOI: 10.1007/BF00143950

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  12 in total

1.  [Experimental studies on neurotoxicity of ethambutol and chloramphenicol - pathological and macroautoradiographic studies].

Authors:  N Wakata; E Satoyoshi
Journal:  Rinsho Shinkeigaku       Date:  1975-09

2.  Electro-ophthalmology and side-effects of drugs.

Authors:  G H Van Lith
Journal:  Doc Ophthalmol       Date:  1977-09-30       Impact factor: 2.379

3.  Pattern disappearance visually evoked cortical potential in the diseases of visual pathway.

Authors:  N Toyonaga; Y Kakisu; E Adachi
Journal:  Doc Ophthalmol       Date:  1986-06-16       Impact factor: 2.379

4.  [Visually evoked answers in patients with ethambutol damage].

Authors:  E Adachi-Usami; F J Kellermann; R Makabe
Journal:  Ber Zusammenkunft Dtsch Ophthalmol Ges       Date:  1974

5.  Distribution of pattern-evoked potentials in the facial area.

Authors:  E Adachi-Usami; N Kuroda; I Nakajima
Journal:  Am J Ophthalmol       Date:  1983-12       Impact factor: 5.258

6.  Small amounts of zinc stimulate rapid axonal transport in vitro.

Authors:  A Edström; H Mattsson
Journal:  Brain Res       Date:  1975-03-14       Impact factor: 3.252

7.  Histopathology of experimental ethambutol intoxication.

Authors:  S Lessell
Journal:  Invest Ophthalmol Vis Sci       Date:  1976-09       Impact factor: 4.799

8.  Visual evoked potentials in the detection of subclinical optic toxic effects secondary to ethambutol.

Authors:  C Yiannikas; J C Walsh; J G McLeod
Journal:  Arch Neurol       Date:  1983-10

9.  Ethambutol changes the color coding of carp retinal ganglion cells reversibly.

Authors:  B W van Dijk; H Spekreijse
Journal:  Invest Ophthalmol Vis Sci       Date:  1983-01       Impact factor: 4.799

10.  Nutritional effects of zinc on ocular and systemic physiology.

Authors:  D P Yolton
Journal:  J Am Optom Assoc       Date:  1981-05
View more
  4 in total

1.  Multifocal electroretinogram demonstrated macular toxicity associated with ethambutol related optic neuropathy.

Authors:  T Y Y Lai; W-M Chan; D S C Lam; E Lim
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Multifocal ERG in ethambutol associated visual loss.

Authors:  R S Behbehani; E L Affel; R C Sergott; P J Savino
Journal:  Br J Ophthalmol       Date:  2005-08       Impact factor: 4.638

3.  Ethambutol toxicity: Expert panel consensus for the primary prevention, diagnosis and management of ethambutol-induced optic neuropathy.

Authors:  Rohit Saxena; Digvijay Singh; Swati Phuljhele; V Kalaiselvan; Satya Karna; Rashmin Gandhi; Anupam Prakash; Rakesh Lodha; Anant Mohan; Vimla Menon; Rajeev Garg
Journal:  Indian J Ophthalmol       Date:  2021-12       Impact factor: 1.848

Review 4.  Retinal Ganglion Cells-Diversity of Cell Types and Clinical Relevance.

Authors:  Ungsoo Samuel Kim; Omar A Mahroo; John D Mollon; Patrick Yu-Wai-Man
Journal:  Front Neurol       Date:  2021-05-21       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.